Healthcare

Cochlear (ASX:COH) operates through three principal revenue categories: cochlear implants, services and acoustics. Implant systems include surgically implanted devices and external sound processors designed for people with severe to profound hearing loss. Services revenue includes replacement processors, upgrades, accessories and related offerings for existing …

Ansell (ASX:ANN) operates through Healthcare and Industrial businesses, supplying protection products to hospitals, surgical centres, laboratories, life-science manufacturers and a range of industrial workplaces. Its Healthcare portfolio includes surgical, examination and single-use gloves, together with cleanroom products. The Industrial business provides hand and body …

Telix Pharmaceuticals (ASX:TLX) operates across Precision Medicine, Therapeutics and Telix Manufacturing Solutions. Its commercial imaging agents Illuccix and Gozellix are used in positron emission tomography imaging associated with prostate cancer. Pixclara is an imaging agent for glioma, while further diagnostic programs address kidney cancer …

EBOS Group (ASX:EBO) operates through Healthcare and Animal Care. Its healthcare activities include medicine wholesaling, community pharmacy services, hospital product distribution, medical technology and contract logistics. Through Symbion and its wider distribution network, the group supplies pharmacies and institutional customers, while the TerryWhite Chemmart …

Neuren Pharmaceuticals (ASX:NEU) operates through commercial products and research and development. Its commercial income comes principally from an exclusive worldwide licence of trofinetide, marketed as DAYBUE and DAYBUE STIX in the United States for Rett syndrome. Its licensee manages commercial sales and relevant regional …

Mesoblast (ASX:MSB) develops therapies using donor-derived mesenchymal stromal cells, manufactured for administration without individually harvesting cells from recipients. Ryoncil (remestemcel-L-rknd) is approved in the United States for steroid-refractory acute graft-versus-host disease in paediatric patients aged two months and older. The condition is a serious …

4DMedical (ASX:4DX) develops and commercialises respiratory and cardiothoracic imaging applications for hospitals, radiology providers and other healthcare customers. Its technology processes medical images to describe functional differences between regions of the lungs. The business distributes software through a subscription-based model and commercial arrangements with …